| Vol. 12.02 – 19 January, 2021 |
| |
|
|
| Scientists evaluated the efficacy of TR1801-ADC, a newly developed ADC composed of a MET antibody conjugated to the highly potent pyrrolobenzodiazepine toxin-linker Tesirine. They first evaluated MET expression and subcellular localization in pancreatic cancer cell lines, human tumors and patient derived xenografts. [Clinical Cancer Research] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| | | Researchers showed that shRNA-mediated SIX2 or SIX3 suppression in human pancreatic adult islets impaired insulin secretion. [Genes & Development] |
| | To directly define the roles of insulin and IGF-1 receptors in the maintenance of pluripotency and differentiation of stem cells, scientists knocked out both the receptors in induced pluripotent stem cells. [Molecular Medicine] |
| | Dermal fibroblasts (DF) are critical for effective wound healing, the authors sought to establish whether there were any differences in DF cultured from type 2 diabetes mellitus donors or those without diabetes. [Scientific Reports] |
| |
|
|
| Researchers revealed that increased ataxia-telangiectasia group D-associated gene (ATDC) levels protected cancer cells from reactive oxygen species via stabilization of nuclear factor erythroid 2-related factor 2 (NRF2). [Genes & Development] |
|
|
|
| Investigators evaluated improvements to therapeutic efficacy through combination therapy incorporating NanoKnife and M1 virus. They showed that irreversible electroporation triggered reactive oxygen species-dependent apoptosis in pancreatic cancer cells mediated by phosphatidylinositol-3-kinase/protein kinase B pathway suppression. [Cancer Letters] |
|
|
|
| The authors generated human cancer cell lines of pancreatic and lung origin carrying an inducible shRNA against NRF2 and PERK. They report that PERK-related phosphorylation of NRF2 was only critical in Keap1 wildtype cells to escape its degradation, but showed no direct effect on nuclear import or transcriptional activity of NRF2. [Cell Death & Disease] |
|
|
|
| The roles and mechanisms of dopamine to affect the chemotherapeutic efficacy for pancreatic cancer were studied. Multi-omics results revealed that there was a tumor-promoting vicious cycle involving murine pancreatic cancer cells and tumor-associated macrophages. [Cancer Immunology Immunotherapy] |
|
|
|
| Investigators assessed the effectiveness of hypermethylation at the CpG island of ZNF154, a previously reported multi-cancer specific signature for use in a blood-based cancer detection assay. [Scientific Reports] |
|
|
|
|
| The authors highlight research that has led to a new understanding of retinal pathophysiology during diabetes mellitus and that has uncovered potential new therapeutic avenues to treat this debilitating disease. [Nature Reviews Endocrinology] |
|
|
|
| Investigators cover the accumulating data about the roles of the bromodomain and extraterminal domain (BET) family in innate immunity and discuss the attractive prospect of manipulating the BET family as a new treatment for disease. [Signal Transduction and Targeted Therapy] |
|
|
|
|
| NantKwest, Inc. and ImmunityBio, Inc. announced early interim results of its PD-L1 t-haNK protocols showing median survival rates more than doubled that of the historic rate in patients with advanced metastatic pancreatic cancer for which no other FDA-approved treatment exists. [NantKwest, Inc.] |
|
|
|
| Erytech Pharma S.A. announced the first patient enrolled in a Phase I investigator sponsored trial, named rESPECT, of its lead product eryaspase for the first-line treatment of pancreatic cancer. [Erytech Pharma S.A.] |
|
|
|
|
| February 3 – 23, 2021 Virtual |
|
|
|
|
|
| The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| Harvard Medical School – Boston, Massachusetts, United States |
|
|
|
| Novo Nordisk – Copenhagen, Denmark |
|
|
|
| STEMCELL Technologies, Inc. – Burnaby, British Columbia, Canada |
|
|
|
| Fondazione Human Technopole – Milan, Italy |
|
|
|
|